Dr. M. Sue O'Dorisio, MD, PhD
Claim this profileStudies Neuroendocrine Tumors
1 reported clinical trial
1 drug studied
Area of expertise
1Neuroendocrine Tumors
CXCR4 positive
CXCR4 negative
More about M. Sue O'Dorisio, MD, PhD
Clinical Trial Related7 years of experience running clinical trials · Led 1 trial as a Principal Investigator · 0 Active Clinical TrialsTreatments M. Sue O'Dorisio, MD, PhD has experience with
- Gallium-68 Pentixafor
Breakdown of trials M. Sue O'Dorisio, MD, PhD has run
Neuroendocrine Tumors
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does M. Sue O'Dorisio, MD, PhD specialize in?
M. Sue O'Dorisio, MD, PhD focuses on Neuroendocrine Tumors and other conditions. In particular, much of their work with Neuroendocrine Tumors has involved CXCR4 positive patients, or patients who are CXCR4 negative.
Is M. Sue O'Dorisio, MD, PhD currently recruiting for clinical trials?
No, M. Sue O'Dorisio, MD, PhD is not currently recruiting for any clinical trials. This may change in the future, so check back later.
Are there any treatments that M. Sue O'Dorisio, MD, PhD has studied deeply?
Yes, M. Sue O'Dorisio, MD, PhD has studied treatments such as Gallium-68 Pentixafor.
What is the best way to schedule an appointment with M. Sue O'Dorisio, MD, PhD?
Apply for one of the trials that M. Sue O'Dorisio, MD, PhD is conducting.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.